{"id":"https://openalex.org/W4361816550","doi":"https://doi.org/10.1158/1078-0432.c.6530778","title":"Data from Long-term Follow-up of Patients with Relapsed or Refractory Non\u2013Hodgkin Lymphoma Treated with Venetoclax in a Phase I, First-in-Human Study","display_name":"Data from Long-term Follow-up of Patients with Relapsed or Refractory Non\u2013Hodgkin Lymphoma Treated with Venetoclax in a Phase I, First-in-Human Study","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4361816550","doi":"https://doi.org/10.1158/1078-0432.c.6530778"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.c.6530778","doi":"https://doi.org/10.1158/1078-0432.c.6530778","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.c.6530778","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/1078-0432.c.6530778","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5063755644","display_name":"Matthew Steven Davids","orcid":"https://orcid.org/0000-0003-4529-2003","observed_orcids":["https://orcid.org/0000-0003-4529-2003"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Matthew S. Davids","raw_affiliation_strings":["Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachuetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachuetts","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033407869","display_name":"Andrew Warwick Roberts","orcid":"https://orcid.org/0000-0002-7341-5720","observed_orcids":["https://orcid.org/0000-0002-7341-5720","https://orcid.org/0000-0001-5347-7169"]},"institutions":[{"id":"https://openalex.org/I1320473756","display_name":"The Royal Melbourne Hospital","ror":"https://ror.org/005bvs909","country_code":"AU","type":"funder","lineage":["https://openalex.org/I1320473756","https://openalex.org/I4210158168"]},{"id":"https://openalex.org/I165779595","display_name":"The University of Melbourne","ror":"https://ror.org/01ej9dk98","country_code":"AU","type":"education","lineage":["https://openalex.org/I165779595"]},{"id":"https://openalex.org/I196021976","display_name":"Walter and Eliza Hall Institute of Medical Research","ror":"https://ror.org/01b6kha49","country_code":"AU","type":"nonprofit","lineage":["https://openalex.org/I196021976"]},{"id":"https://openalex.org/I2800555584","display_name":"Peter MacCallum Cancer Centre","ror":"https://ror.org/02a8bt934","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2800555584"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Andrew W. Roberts","raw_affiliation_strings":["Department of Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia","Department of Medical Biology, University of Melbourne, and Walter and Eliza Hall Institute, Melbourne, Australia"],"raw_orcid":"https://orcid.org/0000-0002-7341-5720","affiliations":[{"raw_affiliation_string":"Department of Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia","institution_ids":["https://openalex.org/I1320473756","https://openalex.org/I2800555584"]},{"raw_affiliation_string":"Department of Medical Biology, University of Melbourne, and Walter and Eliza Hall Institute, Melbourne, Australia","institution_ids":["https://openalex.org/I165779595","https://openalex.org/I196021976"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024909755","display_name":"Vaishalee Padgaonkar Kenkre","orcid":"https://orcid.org/0009-0000-4539-9332","observed_orcids":["https://orcid.org/0009-0000-4539-9332"]},"institutions":[{"id":"https://openalex.org/I135310074","display_name":"University of Wisconsin\u2013Madison","ror":"https://ror.org/01y2jtd41","country_code":"US","type":"education","lineage":["https://openalex.org/I135310074"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Vaishalee P. Kenkre","raw_affiliation_strings":["Division of Hematology and Medical Oncology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology and Medical Oncology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin","institution_ids":["https://openalex.org/I135310074"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089428686","display_name":"William G. Wierda","orcid":"https://orcid.org/0000-0002-7357-270X","observed_orcids":["https://orcid.org/0000-0002-7357-270X"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"William G. Wierda","raw_affiliation_strings":["Depart-ment of Leukemia, MD Anderson Cancer Center, Houston, Texas"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Depart-ment of Leukemia, MD Anderson Cancer Center, Houston, Texas","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101856700","display_name":"Abhijeet Kumar","orcid":"https://orcid.org/0000-0001-5235-9099","observed_orcids":["https://orcid.org/0000-0001-5235-9099"]},"institutions":[{"id":"https://openalex.org/I4390039223","display_name":"University of Arizona Cancer Center","ror":"https://ror.org/04tvx8690","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039223"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Abhijeet Kumar","raw_affiliation_strings":["Division of Hematology and Oncology, University of Arizona Cancer Center, Tuscon, Arizona"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology and Oncology, University of Arizona Cancer Center, Tuscon, Arizona","institution_ids":["https://openalex.org/I4390039223"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036828560","display_name":"Thomas J. Kipps","orcid":"https://orcid.org/0000-0002-0064-4549","observed_orcids":["https://orcid.org/0000-0002-0064-4549"]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]},{"id":"https://openalex.org/I4390039236","display_name":"Moores Cancer Center","ror":"https://ror.org/01qkmtm61","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800935791","https://openalex.org/I36258959","https://openalex.org/I4390039236"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Thomas J. Kipps","raw_affiliation_strings":["Division of Hematology-Oncology, Department of Medicine, Univer-sity of California San Diego Moores Cancer Center, San Diego, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology-Oncology, Department of Medicine, Univer-sity of California San Diego Moores Cancer Center, San Diego, California","institution_ids":["https://openalex.org/I36258959","https://openalex.org/I4390039236"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077126341","display_name":"Michelle Boyer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210113058","display_name":"Roche (United Kingdom)","ror":"https://ror.org/024tgbv41","country_code":"GB","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I4210113058"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Michelle Boyer","raw_affiliation_strings":["F. Hoffmann-La Roche, Welwyn Garden City, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"F. Hoffmann-La Roche, Welwyn Garden City, United Kingdom","institution_ids":["https://openalex.org/I4210113058"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053884536","display_name":"Ahmed Hamed Salem","orcid":"https://orcid.org/0000-0002-9261-1583","observed_orcids":["https://orcid.org/0000-0002-9261-1583"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ahmed Hamed Salem","raw_affiliation_strings":["AbbVie Inc., North Chicago, Illinois"],"raw_orcid":"https://orcid.org/0000-0002-9261-1583","affiliations":[{"raw_affiliation_string":"AbbVie Inc., North Chicago, Illinois","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072013221","display_name":"John Carl Pesko","orcid":"https://orcid.org/0000-0002-7568-7762","observed_orcids":["https://orcid.org/0000-0002-7568-7762"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John C. Pesko","raw_affiliation_strings":["AbbVie Inc., North Chicago, Illinois"],"raw_orcid":"https://orcid.org/0000-0002-7568-7762","affiliations":[{"raw_affiliation_string":"AbbVie Inc., North Chicago, Illinois","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077181688","display_name":"Jennifer A. Arzt","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jennifer A. Arzt","raw_affiliation_strings":["AbbVie Inc., North Chicago, Illinois"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AbbVie Inc., North Chicago, Illinois","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091246313","display_name":"Margaret Mantas","orcid":"https://orcid.org/0000-0003-2829-2757","observed_orcids":["https://orcid.org/0000-0003-2829-2757"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Margaret Mantas","raw_affiliation_strings":["AbbVie Inc., North Chicago, Illinois"],"raw_orcid":"https://orcid.org/0000-0003-2829-2757","affiliations":[{"raw_affiliation_string":"AbbVie Inc., North Chicago, Illinois","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075160341","display_name":"Su Y. Kim","orcid":"https://orcid.org/0000-0001-8059-0482","observed_orcids":["https://orcid.org/0000-0001-8059-0482"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Su Y. Kim","raw_affiliation_strings":["AbbVie Inc., North Chicago, Illinois"],"raw_orcid":"https://orcid.org/0000-0001-8059-0482","affiliations":[{"raw_affiliation_string":"AbbVie Inc., North Chicago, Illinois","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5081326206","display_name":"John Francis Seymour","orcid":"https://orcid.org/0000-0003-2188-6835","observed_orcids":["https://orcid.org/0000-0003-2188-6835"]},"institutions":[{"id":"https://openalex.org/I1320473756","display_name":"The Royal Melbourne Hospital","ror":"https://ror.org/005bvs909","country_code":"AU","type":"funder","lineage":["https://openalex.org/I1320473756","https://openalex.org/I4210158168"]},{"id":"https://openalex.org/I165779595","display_name":"The University of Melbourne","ror":"https://ror.org/01ej9dk98","country_code":"AU","type":"education","lineage":["https://openalex.org/I165779595"]},{"id":"https://openalex.org/I196021976","display_name":"Walter and Eliza Hall Institute of Medical Research","ror":"https://ror.org/01b6kha49","country_code":"AU","type":"nonprofit","lineage":["https://openalex.org/I196021976"]},{"id":"https://openalex.org/I2800555584","display_name":"Peter MacCallum Cancer Centre","ror":"https://ror.org/02a8bt934","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2800555584"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"John F. Seymour","raw_affiliation_strings":["Department of Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia","Department of Medical Biology, University of Melbourne, and Walter and Eliza Hall Institute, Melbourne, Australia"],"raw_orcid":"https://orcid.org/0000-0003-2188-6835","affiliations":[{"raw_affiliation_string":"Department of Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia","institution_ids":["https://openalex.org/I1320473756","https://openalex.org/I2800555584"]},{"raw_affiliation_string":"Department of Medical Biology, University of Melbourne, and Walter and Eliza Hall Institute, Melbourne, Australia","institution_ids":["https://openalex.org/I165779595","https://openalex.org/I196021976"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":12,"corresponding_author_ids":["https://openalex.org/A5063755644"],"corresponding_institution_ids":["https://openalex.org/I4210117453"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9419000148773193,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9419000148773193,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.05429999902844429,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/venetoclax","display_name":"venetoclax","score":0.9980000257492065},{"id":"https://openalex.org/keywords/relapsed-refractory-non-hodgkin-lymphoma","display_name":"relapsed/refractory non-Hodgkin lymphoma","score":0.9430000185966492},{"id":"https://openalex.org/keywords/bcl2-inhibitors","display_name":"BCL-2 inhibitor","score":0.921999990940094},{"id":"https://openalex.org/keywords/mantle-cell-lymphoma","display_name":"mantle cell lymphoma","score":0.9309999942779541},{"id":"https://openalex.org/keywords/follicular-lymphoma","display_name":"follicular lymphoma","score":0.9990000128746033},{"id":"https://openalex.org/keywords/marginal-zone-lymphoma","display_name":"marginal zone lymphoma","score":0.8679999709129333},{"id":"https://openalex.org/keywords/waldenstrom-macroglobulinemia","display_name":"Waldenstr\u00f6m macroglobulinemia","score":1.0},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.8859999775886536},{"id":"https://openalex.org/keywords/duration-of-response","display_name":"duration of response","score":0.9330000281333923},{"id":"https://openalex.org/keywords/complete-response","display_name":"complete response","score":0.8899999856948853},{"id":"https://openalex.org/keywords/long-term-outcomes","display_name":"long-term outcomes","score":0.6320000290870667},{"id":"https://openalex.org/keywords/hematological-adverse-events","display_name":"hematologic adverse events","score":0.8240000009536743},{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":0.7820000052452087},{"id":"https://openalex.org/keywords/monotherapy","display_name":"monotherapy","score":0.44699999690055847}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6966879367828369},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6506214141845703},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.6447912454605103},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.6108602285385132},{"id":"https://openalex.org/C2777058707","wikidata":"https://www.wikidata.org/wiki/Q123251","display_name":"Follicular lymphoma","level":3,"score":0.6082934737205505},{"id":"https://openalex.org/C2779675984","wikidata":"https://www.wikidata.org/wiki/Q23671272","display_name":"Venetoclax","level":4,"score":0.5966463685035706},{"id":"https://openalex.org/C2777525834","wikidata":"https://www.wikidata.org/wiki/Q268713","display_name":"Mantle cell lymphoma","level":3,"score":0.5425125360488892},{"id":"https://openalex.org/C2780739268","wikidata":"https://www.wikidata.org/wiki/Q2112244","display_name":"Progression-free survival","level":3,"score":0.4556139409542084},{"id":"https://openalex.org/C2776146153","wikidata":"https://www.wikidata.org/wiki/Q7281276","display_name":"Radioimmunotherapy","level":4,"score":0.44913142919540405},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4469951391220093},{"id":"https://openalex.org/C2778563104","wikidata":"https://www.wikidata.org/wiki/Q18553449","display_name":"Marginal zone B-cell lymphoma","level":5,"score":0.44297274947166443},{"id":"https://openalex.org/C2776391228","wikidata":"https://www.wikidata.org/wiki/Q4118092","display_name":"Macroglobulinemia","level":3,"score":0.4320051074028015},{"id":"https://openalex.org/C2778476748","wikidata":"https://www.wikidata.org/wiki/Q1138590","display_name":"Non-Hodgkin's lymphoma","level":3,"score":0.4165664613246918},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.41284430027008057},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.2819690704345703},{"id":"https://openalex.org/C2779921676","wikidata":"https://www.wikidata.org/wiki/Q6760434","display_name":"Marginal zone","level":4,"score":0.23741444945335388},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.1941540539264679},{"id":"https://openalex.org/C2778453870","wikidata":"https://www.wikidata.org/wiki/Q188930","display_name":"B cell","level":3,"score":0.17836031317710876},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.14588713645935059},{"id":"https://openalex.org/C2777938653","wikidata":"https://www.wikidata.org/wiki/Q1088156","display_name":"Chronic lymphocytic leukemia","level":3,"score":0.14397293329238892},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.097373366355896},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.08158847689628601},{"id":"https://openalex.org/C87355193","wikidata":"https://www.wikidata.org/wiki/Q411","display_name":"Astrobiology","level":1,"score":0.0},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1158/1078-0432.c.6530778","doi":"https://doi.org/10.1158/1078-0432.c.6530778","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.c.6530778","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"doi:10.1158/1078-0432.c.6530778.v1","doi":"https://doi.org/10.1158/1078-0432.c.6530778.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.c.6530778.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.c.6530778","doi":"https://doi.org/10.1158/1078-0432.c.6530778","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.c.6530778","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320332193","display_name":"Genentech","ror":"https://ror.org/04gndp242"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":18,"referenced_works":["https://openalex.org/W1970961784","https://openalex.org/W2133201432","https://openalex.org/W2145676206","https://openalex.org/W2529782638","https://openalex.org/W2554496337","https://openalex.org/W2582696216","https://openalex.org/W2602734365","https://openalex.org/W2604580699","https://openalex.org/W2795301499","https://openalex.org/W2800133359","https://openalex.org/W2808653175","https://openalex.org/W2883570202","https://openalex.org/W2955463869","https://openalex.org/W2987862961","https://openalex.org/W3105196097","https://openalex.org/W3133932532","https://openalex.org/W4233562659","https://openalex.org/W4243813221"],"related_works":["https://openalex.org/W3164555487","https://openalex.org/W2912937327","https://openalex.org/W2892307726","https://openalex.org/W2907545704","https://openalex.org/W2952496787","https://openalex.org/W7108710181","https://openalex.org/W2977159719","https://openalex.org/W2531109441","https://openalex.org/W2582696216","https://openalex.org/W2273537491"],"abstract_inverted_index":{"AbstractPurpose:":[0],"We":[1],"previously":[2],"reported":[3],"a":[4,17,119,231,240],"44%":[5],"overall":[6],"response":[7,27,52,109,268],"rate":[8],"(ORR)":[9],"with":[10,33,58,203,221,244],"the":[11,70,127,265],"oral":[12],"BCL-2":[13],"inhibitor":[14],"venetoclax":[15,86],"in":[16,31,55,88,177,239,251],"phase":[18],"I":[19],"study":[20],"of":[21,73,91,108,122,170,242,267],"relapsed/refractory":[22],"non\u2013Hodgkin":[23],"lymphoma":[24,36,44,65],"(NHL).":[25],"Complete":[26],"(CR)":[28],"was":[29,134,154],"observed":[30],"patients":[32,57,81,133,243],"mantle":[34],"cell":[35],"[(MCL),":[37],"21%,":[38],"n":[39,47],"=":[40,48,83],"6/28]":[41],"and":[42,50,62,78,111,148,166,184,200,235,248],"follicular":[43],"[(FL),":[45],"17%,":[46],"5/29],":[49],"partial":[51],"(PR)":[53],"noted":[54],"several":[56],"Waldenstr\u00f6m":[59],"macroglobulinemia":[60],"(WM),":[61],"marginal":[63],"zone":[64],"(MZL).":[66],"Here,":[67],"we":[68],"report":[69],"long-term":[71],"outcomes":[72],"these":[74],"four":[75],"cohorts.":[76],"Patients":[77],"Methods:":[79],"All":[80,190],"(n":[82],"106)":[84],"received":[85],"monotherapy":[87,229],"dose":[89],"cohorts":[90],"200":[92],"to":[93,263,269],"1,200":[94],"mg":[95],"daily":[96],"until":[97],"disease":[98],"progression":[99],"or":[100],"unacceptable":[101],"toxicity.":[102],"ORR,":[103],"progression-free":[104],"survival":[105],"(PFS),":[106],"duration":[107],"(DoR),":[110],"adverse":[112],"events":[113],"(AEs)":[114],"were":[115,194],"evaluated.":[116],"Results:":[117],"At":[118],"median":[120,128,152],"follow-up":[121],"38.5":[123],"months":[124,141,159],"(range,":[125],"30.0\u201346.5),":[126],"PFS":[129],"for":[130],"all":[131],"106":[132],"5.4":[135],"[95%":[136],"confidence":[137],"interval":[138],"(CI),":[139],"3.5\u20138.4]":[140],"(FL,":[142,160],"10.8;":[143],"MCL,":[144,162,246],"11.3;":[145],"MZL,":[146,164,249],"21.2;":[147],"WM,":[149,167,247],"30.4).":[150],"The":[151],"DoR":[153,176],"14.9":[155],"(95%":[156],"CI,":[157],"9.7\u201327.6)":[158],"26.6;":[161],"15.7;":[163],"20.1;":[165],"25.3).":[168],"Achievement":[169],"CR":[171],"versus":[172],"PR":[173],"predicted":[174],"longer":[175],"both":[178],"MCL":[179],"(31.5":[180],"vs.":[181,187],"10.1":[182],"months)":[183],"FL":[185],"(37.6":[186],"9.7":[188],"months).":[189],"grade":[191],"hematologic":[192],"AEs":[193,213],"infrequent:":[195],"neutropenia":[196],"(19%),":[197,199],"anemia":[198],"thrombocytopenia":[201],"(17%),":[202],"no":[204],"new":[205],"cytopenias":[206],"after":[207,224],"2":[208],"years":[209],"on":[210,260],"therapy.":[211],"Nonhematologic":[212],"included":[214],"nausea":[215],"(49%),":[216],"diarrhea":[217],"(46%),":[218],"fatigue":[219],"(44%),":[220],"decreased":[222],"incidence":[223],"1":[225],"year.":[226],"Conclusions:":[227],"Venetoclax":[228],"has":[230],"manageable":[232],"safety":[233],"profile":[234],"achieves":[236],"durable":[237],"responses":[238],"subset":[241],"FL,":[245],"particularly":[250],"those":[252],"who":[253],"achieve":[254],"CR.":[255],"Further":[256],"research":[257],"is":[258],"warranted":[259],"combination":[261],"strategies":[262],"enhance":[264],"durability":[266],"venetoclax.":[270]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-04-05T00:00:00"}